Bidirectional Relationship Between Primary Sjögren Syndrome and Non-Hodgkin Lymphoma: A Nationwide Taiwanese Population-based Study

REFERENCES

1. 1.↵
   1. Mariette X,
   2. Criswell LA

   . Primary Sjögren’s syndrome. N Engl J Med 2018;378:931–9.

   OpenUrlPubMed
2. 2.↵
   1. Vesely MD,
   2. Kershaw MH,
   3. Schreiber RD,
   4. Smyth MJ

   . Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011;29:235–71.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Lu H,
   2. Ouyang W,
   3. Huang C

   . Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221–33.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Wang LH,
   2. Wang WM,
   3. Lin SH,
   4. Shieh CC

   . Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin’s lymphoma: a nationwide population-based study. Rheumatology 2019;58:1245–9.

   OpenUrl
5. 5.↵
   1. Wang LH,
   2. Yang YJ,
   3. Cheng WC,
   4. Wang WM,
   5. Lin SH,
   6. Shieh CC

   . Higher risk for hematological malignancies in inflammatory bowel disease: a nationwide population-based study in Taiwan. Am J Gastroenterol 2016;111:1313–9.

   OpenUrl
6. 6.↵
   1. Wang LH,
   2. Wang WM,
   3. Hsu SM,
   4. Lin SH,
   5. Shieh CC

   . Risk of overall and site-specific cancers in Behçet’s disease: a nationwide population-based study in Taiwan. J Rheumatol 2015;42:879–84.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Weng MY,
   2. Huang YT,
   3. Liu MF,
   4. Lu TH

   . Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjögren’s syndrome in Taiwan. Ann Rheum Dis 2012;71:524–7.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Brito-Zerón P,
   2. Kostov B,
   3. Fraile G,
   4. Caravia-Durán D,
   5. Maure B,
   6. Rascón FJ,
   7. et al.

   Characterization and risk estimate of cancer in patients with primary Sjögren syndrome. J Hematol Oncol 2017;10:90.

   OpenUrl
9. 9.↵
   1. Giat E,
   2. Ehrenfeld M,
   3. Shoenfeld Y

   . Cancer and autoimmune diseases. Autoimmun Rev 2017;16:1049–57.

   OpenUrl
10. 10.↵
    1. Fallah M,
    2. Liu X,
    3. Ji J,
    4. Försti A,
    5. Sundquist K,
    6. Hemminki K

    . Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study. Ann Oncol 2014;25:2025–30.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. National Health Insurance Administration

    . Patients with catastropic illnesses or rare diseases. [Internet. Accessed June 19, 2020.] Available from: https://www.nhi.gov.tw/english/Content_List.aspx?n=F5B8E49CB4548C60&topn=1D1ECC54F86E9050
12. 12.↵
    1. Chen YC,
    2. Yeh HY,
    3. Wu JC,
    4. Haschler I,
    5. Chen TJ,
    6. Wetter T

    . Taiwan’s National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 2011;86:365–80.

    OpenUrlCrossRef
13. 13.↵
    1. Vitali C,
    2. Bombardieri S,
    3. Jonsson R,
    4. Moutsopoulos HM,
    5. Alexander EL,
    6. Carsons SE,
    7. et al.

    Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Columbia University, Mailman School of Public Health

    . Cohort study: standardized incidence ratio (SIR). [Internet. Accessed June 19, 2020.] Available from: http://epiville.ccnmtl.columbia.edu/99interactive/sir.html
15. 15.↵
    1. Baecklund E,
    2. Smedby KE,
    3. Sutton LA,
    4. Askling J,
    5. Rosenquist R

    . Lymphoma development in patients with autoimmune and inflammatory disorders — what are the driving forces? Semin Cancer Biol 2014;24:61–70.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Igoe A,
    2. Scofield RH

    . Autoimmunity and infection in Sjögren’s syndrome. Curr Opin Rheumatol 2013;25:480–7.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Couronné L,
    2. Bachy E,
    3. Roulland S,
    4. Nadel B,
    5. Davi F,
    6. Armand M,
    7. et al.

    From hepatitis C virus infection to B-cell lymphoma. Ann Oncol 2018;29:92–100.

    OpenUrl
18. 18.↵
    1. Buglione M,
    2. Cavagnini R,
    3. Di Rosario F,
    4. Maddalo M,
    5. Vassalli L,
    6. Grisanti S,
    7. et al.

    Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: xerostomia and trismus (Part 2). Literature review and consensus statement. Crit Rev Oncol Hematol 2016;102:47–54.

    OpenUrl
19. 19.↵
    1. Paik JS,
    2. Cho WK,
    3. Lee SE,
    4. Choi BO,
    5. Jung SE,
    6. Park GS,
    7. et al.

    Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma. Ann Hematol 2012;91:1393–401.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Schmalzing M

    . The relationship of lymphoma and lupus — at least bidirectional. Rheumatology 2019;58:1131–2.

    OpenUrl